For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.
Novo Nordisk navigates competition and guidance challenges with strong profitability and upcoming oral Wegovy opportunities.
When a man suddenly collapsed during a televised White house event about weight-loss drugs, it sparked widespread speculation ...